Description

BSE announces listing of 1,70,06,802 new equity shares of Gayatri Bioorganics Limited issued pursuant to BIFR order, effective December 3, 2025.

Summary

BSE has approved the listing of 1,70,06,802 new equity shares of Gayatri BioOrganics Limited (Scrip Code: 524564) for trading with effect from December 3, 2025. These shares were issued at Rs. 11.76 per share to promoters on a preferential basis pursuant to an order from the Board of Industrial and Financial Reconstruction (BIFR). The shares are subject to lock-in periods extending until June 2026 and June 2027.

Key Points

  • Total new shares listed: 1,70,06,802 equity shares of Rs. 10/- face value each
  • Issue price: Rs. 11.76 per share
  • Allotment basis: Preferential allotment to promoters pursuant to BIFR order
  • Date of allotment: October 13, 2016
  • Trading commencement: December 3, 2025
  • ISIN: INE052E01015
  • Distinctive numbers: 61781341 to 78788142
  • New shares rank pari-passu with existing equity shares

Regulatory Changes

No new regulatory changes introduced. This is a standard listing notification following BIFR-mandated preferential allotment to promoters.

Compliance Requirements

  • Trading members are informed to note the new securities for trading purposes
  • Lock-in restrictions must be observed as per the schedule provided
  • The shares cannot be transferred or sold during the lock-in period

Important Dates

  • Allotment Date: October 13, 2016
  • Trading Effective Date: December 3, 2025 (Wednesday)
  • Lock-in Expiry (12,49,173 shares): June 30, 2026
  • Lock-in Expiry (1,57,57,629 shares): June 30, 2027

Impact Assessment

Market Impact: Medium - The listing increases the company’s equity capital significantly. However, with lock-in periods extending until 2027, immediate market impact is limited as most shares (92.7%) remain locked until June 2027.

Shareholding Impact: The preferential allotment to promoters will likely increase promoter holding percentage, strengthening promoter control. The issuance was part of BIFR restructuring proceedings, suggesting the company underwent financial rehabilitation.

Liquidity Impact: Minimal immediate impact on free float as all newly listed shares are subject to lock-in restrictions. Gradual increase in tradable shares expected post June 2026 and 2027.

Investor Consideration: Existing shareholders should note the dilution in equity and assess the impact on earnings per share and voting rights.

Impact Justification

New equity listing affecting capital structure with significant lock-in periods; material for existing shareholders but routine corporate action